290328-57-3 Usage
Uses
Used in Pharmaceutical Industry:
(S)-3-(Methylsulfonyl)pyrrolidine is used as a key intermediate in the synthesis of pharmaceutical compounds for its ability to be incorporated into the molecular structures of potential drugs. Its unique chiral properties allow for the creation of enantiomerically pure compounds, which is crucial for ensuring the desired biological activity and minimizing side effects.
Used in Agrochemical Industry:
In the agrochemical sector, (S)-3-(Methylsulfonyl)pyrrolidine serves as a versatile building block for the development of new agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds can enhance their effectiveness and selectivity, leading to improved crop protection and reduced environmental impact.
Used in Organic Synthesis:
(S)-3-(Methylsulfonyl)pyrrolidine is utilized as a valuable chemical intermediate in organic synthesis, enabling the creation of a wide range of other chemical compounds. Its presence in these reactions can facilitate the formation of complex molecular structures, contributing to the advancement of materials science and the discovery of novel chemical entities with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 290328-57-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,0,3,2 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 290328-57:
(8*2)+(7*9)+(6*0)+(5*3)+(4*2)+(3*8)+(2*5)+(1*7)=143
143 % 10 = 3
So 290328-57-3 is a valid CAS Registry Number.
290328-57-3Relevant academic research and scientific papers
NOVEL HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE BCR-ABL INHIBITORS
-
, (2017/12/09)
Disclosed is a compound of Formula (Ⅰ) or a pharmaceutically acceptable salt thereof, wherein the variables are described herein. Also disclosed is a process for the preparation of compounds, their pharmaceutical compositions comprising the same as an active ingredient, methods using said compositions in the treatment of various disorders, and use of the compounds in the manufacture of a medicament in inhibition of the enzymatic activities of ABL1, ABL2 and related chimeric proteins.
